Caffeine-free alertness and mental focus
Five human RCTs demonstrate enXtra® significantly improves alertness, attention, and cognitive performance for up to 5 hours post-dose without caffeine or stimulant mechanisms. This makes it uniquely valuable for caffeine-sensitive populations, evening use, or as a non-stimulant nootropic foundation.
Caffeine duration extension and synergy
A landmark double-blind crossover RCT found enXtra® combined with 40 mg caffeine sustained cognitive benefits for the full 5-hour study period — while caffeine alone showed declining effects after 1–2 hours. enXtra® appears to extend caffeine's window of cognitive efficacy, enabling lower caffeine doses to provide longer-lasting focus.
Sustained attention and processing speed
enXtra® improves performance on sustained attention tasks, reaction time, and information processing speed — cognitive domains critical for productivity, sport performance, and academic performance. Effects are maintained throughout the day without the afternoon crash associated with caffeine or stimulants.
Mood and wellbeing support
Clinical studies report improved subjective mood, reduced mental fatigue, and enhanced overall wellbeing with enXtra® supplementation. These effects occur through non-adrenergic mechanisms, distinguishing enXtra® from stimulant-based energy products.
Dopamine and acetylcholine pathway modulation
Acetoxy chavicol acetate (ACA) and related phenylpropanoids from A. galanga modulate dopaminergic and cholinergic neurotransmitter pathways — increasing dopamine availability in prefrontal cortex circuits governing attention and motivation, and enhancing acetylcholine signaling for working memory and learning.
PDE inhibition and cyclic AMP elevation
Galangal constituents inhibit phosphodiesterase (PDE) enzymes, raising intracellular cyclic AMP levels in neurons. Elevated cAMP activates PKA signaling cascades that enhance synaptic plasticity, working memory, and the cellular mechanisms of attention — a fundamentally different mechanism from caffeine's adenosine antagonism.
Non-adrenergic alertness mechanism
Unlike stimulants that trigger norepinephrine and epinephrine release via adrenergic pathways, enXtra® produces alertness through CNS-specific mechanisms without peripheral cardiovascular activation. This explains why enXtra® does not increase heart rate or blood pressure at clinical doses.
Randomized, double-blind, placebo-controlled crossover study examining enXtra® (300 mg), caffeine (40 mg), enXtra® + caffeine combination, and placebo on cognitive performance over 5 hours in healthy adults.
Healthy adults. 5-hour double-blind crossover design.
enXtra® alone significantly improved alertness and attention vs. placebo for the full 5 hours. Caffeine alone showed declining effects after 1–2 hours. enXtra® + caffeine combination maintained significant cognitive benefits throughout the entire 5-hour period — demonstrating unique caffeine-extending synergy.
Second independent double-blind RCT validating enXtra® cognitive effects in healthy adults using computerized cognitive battery.
Healthy adults. Double-blind crossover design.
enXtra® significantly improved alertness, attention scores, and reaction time vs. placebo. Effects confirmed across multiple cognitive domains. No changes in heart rate or blood pressure confirming non-stimulant mechanism. Excellent tolerability.